Application Note: IHC-P: 1:200-1:400. FCM: 1:20-1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 60
Form: Liquid
Buffer (with preservative): 0.01M TBS, 1% BSA, 50% Glycerol, 0.02% Proclin300.
Concentration: 1 mg/ml (Please refer to the vial label for the specific concentration.)
Background: Predicted to be involved in several processes, including B cell activation; B cell receptor signaling pathway; and regulation of signal transduction. Predicted to act upstream of or within positive regulation of release of sequestered calcium ion into cytosol. Predicted to be located in plasma membrane. Predicted to be part of protein-containing complex. Predicted to be active in external side of plasma membrane. Human ortholog(s) of this gene implicated in common variable immunodeficiency 3. Orthologous to human CD19 (CD19 molecule). [provided by Alliance of Genome Resources, Nov 2024]
Uniprot ID: A6I950
Antigen Species: Rat
Immunogen: KLH conjugated synthetic peptide derived from rat CD19 (485-556aa)
Purification: Purified by Protein A
Conjugation: Unconjugated
Full Name: CD19 antigen
Deutsch
English
